The Enterprise Value as of December 2025 (TTM) for Mayne Pharma Group Limited (MYX.AX) is 246.29M

According to Mayne Pharma Group Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 246.29M. This represents a change of -37.96% compared to the average of 397.01M of the last 4 quarters.

Mayne Pharma Group Limited (MYX.AX) Historical Enterprise Value (quarterly & annually)

How has MYX.AX Enterprise Value performed in the past?

The mean historical Enterprise Value of Mayne Pharma Group Limited over the last ten years is 1.14B. The current 246.29M Enterprise Value has changed 2.07% with respect to the historical average. Over the past ten years (40 quarters), MYX.AX's Enterprise Value was at its highest in in the December 2016 quarter at 2.18B. The Enterprise Value was at its lowest in in the January 2007 quarter at 0.

Mayne Pharma Group Limited (MYX.AX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Mayne Pharma Group Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Mayne Pharma Group Limited (MYX.AX) Average Enterprise Value

How has MYX.AX Enterprise Value performed in the past?

The current Enterprise Value of Mayne Pharma Group Limited (MYX.AX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Mayne Pharma Group Limited (MYX.AX) Enterprise Value vs. Peers

How is MYX.AX’s Enterprise Value compared to its peers?

Mayne Pharma Group Limited’s Enterprise Value is greater than Imricor Medical Systems, Inc. (209.87M), less than Artrya Limited (438.04M), less than Immutep Limited (493.55M), less than Pacific Smiles Group Limited (396.60M), less than AFT Pharmaceuticals Limited (402.24M), greater than Anteris Technologies Ltd (222.00M), greater than Botanix Pharmaceuticals Limited (203.79M), less than Dimerix Limited (289.05M), greater than Orthocell Limited (221.46M), less than Monash IVF Group Limited (490.38M),

Build a custom stock screener for Mayne Pharma Group Limited (MYX.AX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Mayne Pharma Group Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Mayne Pharma Group Limited (MYX.AX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Mayne Pharma Group Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.